Behavioural modification and lifestyle adjustments are the first step in treating obesity. Whilst these are important in treating obesity, it is difficult to achieve or sustain the process of weight loss, especially long-term through these alone. Pharmacotherapy has quickly surfaced as an alternative therapeutic approach to intensive lifestyle intervention; essentially bridging the gap between behaviour changes and more intense treatment such as surgery. In this episode of Unlearn to Learn, we’ll be delving into the world of Pharmacotherapy with Dr Caroline Apovian. Caroline joins Alexander to discuss what FDA approved medicine is currently being used to treat obesity, as well as some of the benefits and risks associated with drug treatment. As always on the podcast, they’ll debunk some common myths surrounding obesity medication before analysing the science behind it and examining the relationship and potential causality between multiple different drugs and the disease itself. Spread the word: Follow, like, share, review We want to build a Unlearn to Learn community. That starts with helping to spread the word about this series. COME AND SAY HELLO: We’d love to see your reviews and feedback – let us know what you think, and any questions you have with #UnlearntoLearn on Twitter. The team @worldobesity will be in touch, do follow us there for more information on Unlearn to Learn. Want to tell us more? You can tell us more or more in-depth feedback here - Unlearn to Learn - What do you think? Unlearn to Learn is produced in partnership with The Podcast Guys